Efficacy and safety of recombinant human lymphotoxin-α derivative with cisplatin and fluorouracil in patients with metastatic esophageal squamous cell carcinoma: A randomized, multicenter, open-label, controlled, phase 2b trial

Author:

Wang Feng-hua12,Wang Yun12,Sun Guo-ping3,Chen Jian-hua4,Lin Ying-cheng5,Liu Wei6,Zheng Rong-sheng7,Chen Jia8,Zhang He-long9,Lan Hai-tao10,Qi Jun11,Liu Yang-qing12,Deng Yan-ming13,Zhao Heng14,Xiong Jian-ping15,Xu Qing16,Jiang Wen-qi12,Li Yu-hong12ORCID

Affiliation:

1. Department of Medical Oncology; Sun Yat-sen University Cancer Center; Guangzhou People's Republic of China

2. State Key Laboratory of Oncology in South China; Sun Yat-sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangdong Esophageal Cancer Institute; Guangzhou People's Republic of China

3. Department of Medical Oncology; First Affiliated Hospital of Anhui Medical University; Hefei People's Republic of China

4. Department of Medical Oncology; Hunan Cancer Hospital; Changsha People's Republic of China

5. Department of Medical Oncology; Cancer Hospital of Shantou University Medical College; Shantou People's Republic of China

6. Department of Oncology; Fourth Hospital of Hebei Medical University; Shijiazhuang People's Republic of China

7. Department of Medical Oncology; Anhui Provincial Cancer Hospital; Bengbu People's Republic of China

8. Department of Oncology; Jiangsu Cancer Hospital; Nanjing People's Republic of China

9. Department of Oncology; Tangdu Hospital, Fourth Military Medical University; Xi'an People's Republic of China

10. Department of Oncology; Sichuan Provincial People's Hospital; Chengdu People's Republic of China

11. Department of Thoracic Surgery; Chongqing Cancer Hospital; Chongqing People's Republic of China

12. Department of Medical Oncology; Huai'an First People's Hospital; Huai'an People's Republic of China

13. Department of Medical Oncology; First People's Hospital of Foshan; Foshan People's Republic of China

14. Department of Thoracic Surgery; Shanghai Chest Hospital, Shanghai Jiaotong University; Shanghai People's Republic of China

15. Department of Oncology; First Affiliated Hospital of Nanchang University; Nanchang People's Republic of China

16. Department of Oncology; Shanghai 10 People's Hospital; Shanghai People's Republic of China

Funder

Fudan-Zhangjiang Bio-Pharmaceutical Company, Ltd.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference25 articles.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3